| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 06/25/2002 | US6410326 Destroying human tumor cells; obtain tumor cells, transform with replication defective vector, incubate with prodrug, monitor destruction of cells |
| 06/25/2002 | US6410317 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same |
| 06/25/2002 | US6410303 Yeast culture with amplified shelf-life for use in baked goods |
| 06/25/2002 | US6410302 Expression vector for the efficient generation of ethanol |
| 06/25/2002 | US6410301 Genetically engineered cells; for use in generating carcinogenic agents |
| 06/25/2002 | US6410296 Herpes virus proteinase and method of assaying |
| 06/25/2002 | US6410295 Enzymatic polypeptide for use in processing starch; for use in detergents, cleaning, textile treatment, ethanol generation and as fuel |
| 06/25/2002 | US6410294 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 06/25/2002 | US6410292 Cultivating a wild-type strain to produce a supernatant |
| 06/25/2002 | US6410291 Polypeptides having haloperoxidase activity |
| 06/25/2002 | US6410290 Catalases |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 06/25/2002 | US6410288 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
| 06/25/2002 | US6410287 Granules; for use in detergents |
| 06/25/2002 | US6410286 Asparaginyl tRNA synthetase from Staphylococcus Aureus |
| 06/25/2002 | US6410285 Alanyl tRNA synthetase from Streptococcus pneumoniae |
| 06/25/2002 | US6410280 Generating ubiquinone 10; obtain cells, transfom, culture transformed cells, recovering the ubiquinone-10 from culture. |
| 06/25/2002 | US6410277 DNA polymersases with enhanced length of primer extension |
| 06/25/2002 | US6410273 Generating methylated nucleotide sequences; obtain prokaryotc cell, transform with nucleotide sequences and expression vector, culture cells, recover methylated nucleotide sequences |
| 06/25/2002 | US6410272 Production of thrombin inhibitors |
| 06/25/2002 | US6410269 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 06/25/2002 | US6410264 Pichia pastoris gene sequences and methods for their use |
| 06/25/2002 | US6410263 Histidine kinase |
| 06/25/2002 | US6410259 Fermenting microbial strains |
| 06/25/2002 | US6410256 Method of making biofilms |
| 06/25/2002 | US6410253 Cholesterol oxidase |
| 06/25/2002 | US6410230 Detection gene hybridization |
| 06/25/2002 | US6410226 Quantitative analysis; calibration |
| 06/25/2002 | US6410224 Cleavage of protein using enzyme; therapy for inflammation, asthma, rheumatic diseases, autoimmune diseases |
| 06/25/2002 | US6410221 Entomopoxvirus expression system |
| 06/25/2002 | US6410017 Personal care compositions containing active proteins tethered to a water insoluble substrate |
| 06/25/2002 | US6410014 Administering protein-tyrosine kinase chimeras capable of directing cytotoxic t lymphocytes to specifically recognize and lyse target cells |
| 06/25/2002 | US6410011 Treatment of restenosis by gene therapy, comprising the administration of a recombinant adenovirus containing a suicide gene |
| 06/25/2002 | CA2245462C Methods of modulating cell proliferation through telomerase modulation |
| 06/25/2002 | CA2194393C Mammalian telomerase |
| 06/25/2002 | CA2135648C Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 06/25/2002 | CA2095300C Use of genetically modified cells to treat defects, disease or damage of the central nervous system |
| 06/25/2002 | CA2094347C A method of producing a factor viii preparation |
| 06/25/2002 | CA2085881C Dna encoding mammalian phosphodiesterases |
| 06/23/2002 | WO2002040654A2 A human serpin secreted from lymphoid cells lsi-01 |
| 06/23/2002 | CA2429179A1 Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01 |
| 06/20/2002 | WO2002048400A1 Method of estimating risk of the expression of side effect caused by the administration of compound metabolized, either per se or as its metabolic intermediate, by ugt1a1 enzyme |
| 06/20/2002 | WO2002048397A2 Regulation of human adenylate cyclase, type vii |
| 06/20/2002 | WO2002048394A1 Infection resistant plants and methods for their generation |
| 06/20/2002 | WO2002048382A2 Method for the production of a heterologous protein by a fungus |
| 06/20/2002 | WO2002048375A2 Purified active hcv ns2/3 protease |
| 06/20/2002 | WO2002048374A1 A NOVEL POLYPEPTIDE, A HUMAN ss-GLUCOSIDURONATASE 26.29 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 06/20/2002 | WO2002048373A1 A novel polypeptide, a human mitochondrial methionyl-trna transformylase 41.14 and the polynucleotide encoding the polypeptide |
| 06/20/2002 | WO2002048372A2 Target enzymes |
| 06/20/2002 | WO2002048371A1 Stress responsive gene involved in peroxysome biosynthesis |
| 06/20/2002 | WO2002048359A1 Magnetic particle membrane-specific protein |
| 06/20/2002 | WO2002048350A1 Transformed yeast presenting cellulose-binding domain on the cell surface layer |
| 06/20/2002 | WO2002048344A2 Gene therapy for prostate cancer: sensibilization of cells to dn a damaging drugs and radiation |
| 06/20/2002 | WO2002048340A2 Transgenci mice containing cashgene disruptions |
| 06/20/2002 | WO2002048336A2 Short peptides from the 'a-region' of protein kinases which selectively modulate protein kinase activity |
| 06/20/2002 | WO2002048335A2 Metal resistant plants and use for phytoremediation |
| 06/20/2002 | WO2002048334A2 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof |
| 06/20/2002 | WO2002048333A2 Novel human kinases and uses thereof |
| 06/20/2002 | WO2002048332A2 Recombinant phytases and uses thereof |
| 06/20/2002 | WO2002048331A2 Active-site engineering of nucleotidyltransferases and enzymatic methods for the synthesis of natural and 'unnatural' udp- and nucleotide sugars |
| 06/20/2002 | WO2002048330A2 21908 and 21911, human guanylate kinase family members and uses thereof |
| 06/20/2002 | WO2002048329A2 Membrane derived caspase-3, compositions comprising the same and methods of use therefor |
| 06/20/2002 | WO2002048328A2 Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof |
| 06/20/2002 | WO2002048327A2 Compositions containing bioemulsifiers and a method for their preparation |
| 06/20/2002 | WO2002048326A2 Human caplain proteins and polynucleotides coding therefor |
| 06/20/2002 | WO2002048325A2 Regulation of human serine palmitoyltransferase |
| 06/20/2002 | WO2002048324A1 Regulation of human ubiquitin-conjugating enzyme e2 |
| 06/20/2002 | WO2002048323A2 Regulation of human uridine kinase |
| 06/20/2002 | WO2002048322A2 Recombinant porcine liver esterases, their use and a method for the production thereof |
| 06/20/2002 | WO2002048321A2 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 06/20/2002 | WO2002048320A2 Crystal structures of retaining glycosyltransferases |
| 06/20/2002 | WO2002048313A2 Senescence-associated plant promotors |
| 06/20/2002 | WO2002048188A1 Plasmodium aldolase polypeptides and nucleic acids |
| 06/20/2002 | WO2002048172A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/20/2002 | WO2002047717A2 Targeted enzyme prodrug therapy |
| 06/20/2002 | WO2002047711A2 Modulators of activity of g-protein-coupled receptor kinases |
| 06/20/2002 | WO2002047710A2 Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancer |
| 06/20/2002 | WO2002047708A2 Selective cox-2 inhibition from edible plant extracts |
| 06/20/2002 | WO2002047701A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 06/20/2002 | WO2002047466A2 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof |
| 06/20/2002 | WO2002042475A8 Gene hd3a inducing flowering of plant and utilization thereof |
| 06/20/2002 | WO2002034894A3 Plant promoter providing high levels of gene expression in fruits |
| 06/20/2002 | WO2002028406A3 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 06/20/2002 | WO2002026755A3 Nucleotide sequences which code for the ppgk gene |
| 06/20/2002 | WO2002020738A3 27877, a phospholipase and uses therefor |
| 06/20/2002 | WO2002020730A3 Manganese lipoxygenase |
| 06/20/2002 | WO2002020495A3 Inhibitors of glycogen synthase kinase 3 |
| 06/20/2002 | WO2002012459A3 Method for improved production of cyanophycin and the secondary products thereof |
| 06/20/2002 | WO2002008866A3 Spread spectrum meter reading system utilizing low-speed/high-power frequency hopping |
| 06/20/2002 | WO2002008393A3 Serine protease from yersinia enterocolitica |
| 06/20/2002 | WO2002007763A3 Helicobacter pylori with modified lipopolysaccharide biosynthesis |
| 06/20/2002 | WO2002004608A3 Regulation of human oligopeptidase a-like enzyme |
| 06/20/2002 | WO2002004600A3 Novel compounds |
| 06/20/2002 | WO2001092504A3 Triacylglycerol lipases from arabidopsis thaliana |
| 06/20/2002 | WO2001090386A3 Gene regulatory region that promotes early seed-specific transcription |
| 06/20/2002 | WO2001085959A3 Regulation of human lysostaphin-like protease |
| 06/20/2002 | WO2001085950A3 Genes of the 1-desoxy-d-xylulose biosynthesis path |
| 06/20/2002 | WO2001083786A3 Stable zymomonas mobilis xylose and arabinose fermenting strains |
| 06/20/2002 | WO2001083559A3 Production and use of protein variants having modified immunogenecity |
| 06/20/2002 | WO2001077113A3 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |